Because of the importance of EZH2-regulated miR-30d expression that modulates KPNB1 in MPNST cell survival and apoptosis in vitro and in vivo [5], pharmacological inhibition of EZH2 represents a promising therapeutic approach for this tumor type. This evidence concerns the gene KPNB1 and neoplasm.